Physician profile
Erica Liu
NPI 1528402633
$28,063.79
in general payments reported to CMS, 2019-2025
16 companies · $7,306 in 2025
The $7,306 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,287 · 2020: $4,198 · 2021: $5,266 · 2022: $3,769 · 2023: $2,571 · 2024: $668 · 2025: $7,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Consulting Fee: $3,550 · Food and Beverage: $2,241 · Travel and Lodging: $912 · Gift: $86.38 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Consulting Fee | $3,550.00 |
| Food and Beverage | $2,241.43 |
| Travel and Lodging | $911.74 |
| Gift | $86.38 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17,723.48 | 2019-2025 | Forum, Iolmaster 700, Humphrey Hfa |
| Carl Zeiss Meditec USA, INC. | $8,061.34 | 2021-2025 | Visumax, Mel 90, Quatera 700 |
| Alcon Vision LLC | $717.37 | 2019-2025 | Clareon, Argos |
| Johnson & Johnson Surgical Vision, INC. | $292.44 | 2019-2025 | Amo Phaco Needle |
| Bausch & Lomb Americas INC. | $204.07 | 2023 | Amvisc, Envista Mx60 Iol |
| Abbvie INC. | $190.73 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $175.63 | 2025 | Xdemvy |
| Shire North American Group INC | $171.50 | 2019 | |
| Harrow Eye, LLC | $147.13 | 2025 | Vevye |
| Janssen Scientific Affairs, LLC | $113.88 | 2021 | |
| Rxsight INC | $85.93 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $48.92 | 2023-2024 | |
| Sight Sciences, INC. | $38.28 | 2020 | |
| Beaver-Visitec International, INC. | $36.45 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $35.68 | 2019-2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $20.96 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.